National & Regional Partnerships

Finding a cure for cancer in our lifetime!

Cancer is a community disease

Chances are, you know someone with cancer. There are over 20 million people living with cancer in the world today. About 1,332,100 more people will be  diagnosed with cancer this year in the United States alone.

  • 77% of  new  cancers will be diagnosed in people over age 55.
  • In the United States, a man’s risk of developing cancer is slightly less than 1 in 2.
  • A U.S. woman’s risk is slightly more than 1 in 3.
  • About 5% to 10% of cancers are hereditary.
  • Childhood cancers account for less than 1% of all cancers diagnosed in the United States.

National and Regional Partners

Oregon Clinical and Translational Research Institute (OCTRI)

The Oregon Clinical and Translational Research Institute (OCTRI) will fundamentally change biomedical research to create a vibrant academic home for clinical/translational investigation. It will leverage existing strengths and remove barriers to the pace and growth of research. At the heart of the OCTRI is a robust partnership between Oregon Health & Science University  and Kaiser Permanente's Center for Health Research that brings together a strong biomedical research university and an innovative practice-based research center associated with a large patient population. The collaboration provides unique opportunities for expansion across the spectrum of human investigation, and sets the stage for major advances in human health.Read more.

LIVESTRONG Foundation/Young Adult Alliance (YAA)

OHSU’s Adolescent and Young Adult Oncology program was founded with support from the Lance Armstrong Foundation. The Lance Armstrong Foundation unites people to fight cancer, believing unity is strength, knowledge is power and attitude is everything. Our Adolescent and Young Adult oncology program is a charter member of the LIVESTRONG Young Adult Alliance. Read more.

American Cancer Society

The OHSU Knight Cancer Institute and the American Cancer Society partner in many ways to bring additional services to our cancer patients. Read more

Leukemia and Lymphoma Society

The Leukemia and Lymphoma Society’s research grants program currently supports more than 400 grants in over 14 countries.  This includes $1.5 million in funds in Oregon and Southwest Washington.  The Society supports chronic myeloid leukemia research by the director of the OHSU Knight Cancer Institute, Dr. Brian Druker, who developed the medication Gleevec.  His laboratory continues to research new treatments for chronic myeloid leukemia.  Read more

Kaiser Permanente Northwest: Oregon Evidence-based Practice Center

The Oregon Evidence-based Practice Center (EPC) is a collaboration of Oregon Health & Science University, the Portland Veterans Affairs Medical Center, and the Kaiser Permanente Center for Health Research. The Oregon EPC was founded in 1997 with funding from the U.S. Agency for Healthcare Research and Quality . It was  reauthorized as an EPC in 2002 and 2007. Read more

Susan G. Komen for the Cure


Oregon State Cancer Registry

The OHSU Knight Cancer Institute Cancer Registry submits data monthly to the Oregon State Cancer Registry (OSCaR). In turn, OSCaR sends data to the National Program of Cancer Registries, part of the U.S. Centers for Disease Control. In addition, data are submitted annually to the American College of Surgeons Commission on Cancer , the National Cancer Data Base  and the Federal Information Processing System (FIPS), which  releases Level II data to the American Cancer Society. The Cancer Registry maintains a wide range of demographic, diagnostic, treatment and outcomes data on all patients with a cancer diagnosis, as well as all primary brain and central nervous system tumors, benign and malignant.  Read more